Nanoparticles and Faraday Rotation Allow Faster Diagnoses
By LabMedica International staff writers Posted on 02 Feb 2017 |
Image: Assistant Professor Shawn Putnam, PhD, of UCF\'s College of Engineering & Computer Science in his laboratory with the frequency-domain Faraday rotation spectroscopy (Photo courtesy of the University of Central Florida).
Magnetic nanoparticles that are coated with an antibody, then aligned in formation within a magnetic field and tallied under laser optics could lead to speedy diagnoses for infectious diseases.
A clinically relevant magneto-optical technique, frequency-domain Faraday rotation spectroscopy (fd-FRS) for characterizing proteins using antibody-functionalized magnetic nanoparticles (MNPs) has been developed.
Bioengineers at the University of Central Florida developed the technique that distinguishes between the Faraday rotation of the solvent, iron oxide core, and functionalization layers of polyethylene glycol polymers (spacer) and model antibody–antigen complexes (anti-BSA/BSA, bovine serum albumin). The technique was combined with predictive analyte binding models quantifies (within an order of magnitude) the number of active binding sites on functionalized MNPs.
The scientists observed a detection sensitivity of ≈10 pg mL−1 and broad detection range of 10 pg mL−1 ≲ cBSA ≲ 100 µg mL−1. Comparative enzyme-linked immunosorbent assay (ELISA) studies are conducted, reproducing the manufacturer advertised BSA ELISA detection limits from 1 ng mL−1 ≲ cBSA ≲ 500 ng mL−1. In addition to the increased sensitivity, broader detection range, and similar specificity, fd-FRS can be conducted in less than 30 minutes, compared to four hours or so with an ELISA.
The authors say that other antigens and their unique antibodies could be substituted for the BSA protein used in the study, allowing medical tests for a wide array of infectious diseases. The proof of concept shows the method could be used to produce biochemical immunology test results in as little as 15 minutes, compared to several hours for ELISA, or enzyme-linked immunosorbent assay, which is currently a standard approach for biomolecule detection. The discovery, if commercialized, could lead to faster test results for human immunodeficiency virus (HIV), Lyme disease, syphilis, rotavirus and other infectious conditions. Shawn A. Putnam, PhD, an assistant professor and a co-author of the study said, “I see no reason why a variation of this technique couldn't be in every hospital throughout the world.” The study was published on January 16, 2017, in the journal Small.
A clinically relevant magneto-optical technique, frequency-domain Faraday rotation spectroscopy (fd-FRS) for characterizing proteins using antibody-functionalized magnetic nanoparticles (MNPs) has been developed.
Bioengineers at the University of Central Florida developed the technique that distinguishes between the Faraday rotation of the solvent, iron oxide core, and functionalization layers of polyethylene glycol polymers (spacer) and model antibody–antigen complexes (anti-BSA/BSA, bovine serum albumin). The technique was combined with predictive analyte binding models quantifies (within an order of magnitude) the number of active binding sites on functionalized MNPs.
The scientists observed a detection sensitivity of ≈10 pg mL−1 and broad detection range of 10 pg mL−1 ≲ cBSA ≲ 100 µg mL−1. Comparative enzyme-linked immunosorbent assay (ELISA) studies are conducted, reproducing the manufacturer advertised BSA ELISA detection limits from 1 ng mL−1 ≲ cBSA ≲ 500 ng mL−1. In addition to the increased sensitivity, broader detection range, and similar specificity, fd-FRS can be conducted in less than 30 minutes, compared to four hours or so with an ELISA.
The authors say that other antigens and their unique antibodies could be substituted for the BSA protein used in the study, allowing medical tests for a wide array of infectious diseases. The proof of concept shows the method could be used to produce biochemical immunology test results in as little as 15 minutes, compared to several hours for ELISA, or enzyme-linked immunosorbent assay, which is currently a standard approach for biomolecule detection. The discovery, if commercialized, could lead to faster test results for human immunodeficiency virus (HIV), Lyme disease, syphilis, rotavirus and other infectious conditions. Shawn A. Putnam, PhD, an assistant professor and a co-author of the study said, “I see no reason why a variation of this technique couldn't be in every hospital throughout the world.” The study was published on January 16, 2017, in the journal Small.
Latest Microbiology News
- High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes
- Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment
- Non-Invasive Stool Test to Diagnose Endometriosis and Help Reduce Disease Progression
- Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR
- Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics
- New Digital PCR Assays Enable Accurate and Sensitive Detection of Critical Pathogens
- Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results
- AST System Delivers Actionable Results for Gram-Negative Bacteria Directly from Positive Blood Cultures
- Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours
- New Rapid Method for Determining Virus Infectivity Could Revolutionize Response to Future Pandemics
- Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings
- Innovative C. Difficile Diagnostic Test Provides Both GDH and Toxin Results within 30 Minutes
- Rapid UTI Test Cuts Detection Time from 3 days to 45 Minutes
- POC STI Test Shortens Time from ED Arrival to Test Results
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections